News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>M Stanley Raises HKEX (00388.HK) TP to $440, Rating Overweight
HKEX (00388.HK) is well-prepared for the delisting of Chinese ADRs, Morgan Stanley’s research report indicated. Mainland financial institutions were believed to be able to pr...
Reset
Send
The window will close in 5 seconds
<Research>M Stanley Raises HKEX (00388.HK) TP to $440, Rating Overweight
Close
Recommend
21
Positive
46
Negative
14
 
SHORT SELL
 
STOCK INFO

HKEX (00388.HK)  -2.000 (-0.525%)    Short selling $236.62M; Ratio 22.792%   is well-prepared for the delisting of Chinese ADRs, Morgan Stanley’s research report indicated. Mainland financial institutions were believed to be able to provide liquidity to the Hong Kong market through the Stock Connect to ensure a smooth transition.

The broker estimated that shifting ADV to HKEX could boost its revenue by approximately 9%. Morgan Stanley raised its target price for HKEX from HKD387 to HKD440, maintaining an Overweight rating.

Related NewsHSBC Research Envisions Fed to Cut Rates by 25 bps Each in Jun/ Sep/ Dec 2025
Despite ongoing uncertainties from U.S. tariff hikes, the broker viewed China’s increasingly innovation-driven growth model and the bottoming of financial risk cycles as playing a more pivotal role in supporting Hong Kong’s IPO and trading activities.

Based on market conditions, the broker revised its ADV assumptions upward, forecasting an ADV of HKD190 billion in 2026. In an upbeat case, considering potential ADV growth from improved market sentiment, the 2026 ADV could reach HKD250 billion.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-15 12:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.